Drug and Alcohol Dependence
Volume 108, Issue 1 , Pages 65-69 , 1 April 2010

Mortality among drug users after discharge from inpatient treatment: An 8-year prospective study

  • Edle Ravndal

      Affiliations

    • University of Oslo, SERAF/Norwegian Centre for Addiction Research, Ullevål Hospital, N-0407 Oslo, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47 23 36 89 74/76; fax: +47 23 36 89 86.
    • ,
  • Ellen J. Amundsen

      Affiliations

    • SIRUS/Norwegian Institute for Alcohol and Drug Research, PO Box 565 Sentrum, N-0105 Oslo, Norway

Received 18 September 2009 ,Revised 12 November 2009 ,Accepted 17 November 2009.

References 

  1. Baca CT, Grant KJ. What heroin users tell us about overdose. J. Addict. Dis. 2007;26:63–68
  2. Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, et al. Drug-related mortality and its impact on adult mortality in eight European countries. Eur. J. Public Health. 2006;16:198–202
  3. Broekaert E, Raes V, Kaplan CD, Coletti M. The design and effectiveness of therapeutic community research in Europe: an overview. Eur. Addict. Res. 1999;5:21–35
  4. Clausen T, Andersen K, Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 2008;94:151–157
  5. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford: Oxford University Press; 1998;
  6. Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ. 2001;322:895–896
  7. Darke S. From the can to the coffin: deaths among recently released prisoners. Addiction. 2007;103:256–257
  8. Darke S, Mattick R, Degenhardt L. Mortality Amongst Illicit Drug Users. Cambridge: Cambridge University Press; 2007;
  9. Darke S, Zador D. Fatal heroin “overdose”: a review. Addiction. 1996;91:1765–1772
  10. Davoli M, Bargagli AM, Perccci CA, Schifano P, Belleudi V, Hickman M, et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007;102:1954–1959
  11. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav. Sci. 1974;19:1–15
  12. Farell M, Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction. 2007;103:251–255
  13. Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, Rosenthal DM. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict. Behav. 2006;31:907–912
  14. Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002;97:39–47
  15. Hodgins DC, El-Guebaly N. More data on the Addiction Severity Index. Reliability and validity with the mentally III substance abusers. J. Nerv. Ment. Dis. 1992;180:197–201
  16. Hser YI, Anglin MD, Chou C. Evaluation of drug abuse treatment: a repeated measures design assessing methadone maintenance. Eval. Rev. 1988;12:547–570
  17. Johnson JE, Finney JW, Moos RH. Predictors of 5-year mortality following inpatient/residential group treatment for substance abuse disorders. Addict. Behav. 2005;30:1300–1316
  18. Kokkevi A, Hartgers C. European Addiction Severity Index (EuropASI). Cost. 1994;A6
  19. Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users are willing to administer naloxone to others. J. Subst. Abuse Treat. 2006;30:129–133
  20. Leonhard CL, Mulvey K, Gastfriend DR, Shwartz M. The Addiction Severity Index. A field study of internal consistency and validity. J. Subst. Abuse Treat. 2000;18:129–135
  21. Millon T. Millon Clinical Multiaxial Inventory-II. Minneapolis, US: National Computer Systems; 1987;
  22. Ødegård E, Amundsen EJ, Kielland KB. Fatal overdoses and deaths from other causes in a cohort of Norwegian drug abusers – a competing risk approach. Drug Alcohol Depend. 2007;89:176–182
  23. Ødegård E, Amundsen EJ, Kielland KB, Kristoffersen R. The contribution of imprisonment and release to fatal overdose and unnatural death among a cohort of Norwegian drug abusers. Addict. Res. Theory. 2009;
  24. Piper T, Rudenstine S, Stancliff S, Sherman S, Nandi V, Clear A, et al. Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct. J. 2007;4:3
  25. Preti A, Miotto P, De Coppi M. Deaths by unintentional illicit drug overdose in Italy, 1984–2000. Drug Alcohol Depend. 2002;66:275–282
  26. Quaglio G, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P. Study of 2708 heroin-related deaths in north-eastern Italy 1985–98 to establish the main cause of death. Addiction. 2001;96:1127–1137
  27. Ravndal E, Vaglum P. Psychopathology, treatment completion and 5 years outcome: a prospective study of drug abusers. J. Subst. Abuse Treat. 1998;15:1–8
  28. Ravndal E, Vaglum P, Lauritzen G. Completion of long-term inpatient treatment of drug abusers: a prospective study from 13 different units. Eur. Addict. Res. 2005;11:180–185
  29. Richert T, Svensson B. Med livet som innsats – injeksjonsmissbruk, risktagande och överdoser (In English: With your life on the line – injecting, risk-taking and overdoses), NAT (Nordic Journal of Alcohol and Drugs). 2008;25:355–376
  30. Rusmidler i Norge . Drugs and Alcohol in Norway. Oslo: Norwegian Institute for Alcohol and Drug Research; 2008;
  31. Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, Ciccarone D, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death. J. Urban Health. 2005;82:303–311
  32. Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse retention and process effects on follow-up outcomes. Drug Alcohol Depend. 1997;47:227–235
  33. Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow-up study. BMJ. 2003;326:959–960
  34. Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008;103:1648–1657

PII: S0376-8716(09)00415-3

doi: 10.1016/j.drugalcdep.2009.11.008

Drug and Alcohol Dependence
Volume 108, Issue 1 , Pages 65-69 , 1 April 2010

Article Tools